Physician
Lags Spine and Sportscare Medical Centers INC
Lags Spine and Sportscare Medical Centers INC was paid $33.42M by Medicaid between Jan 2018 and May 2021, across 105 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 20% of everything it billed.
33Billing provider infoLAGS SPINE AND SPORTSCARE MEDICAL CENTERS INC
SANTA MARIA, CA 93454
SANTA MARIA, CA 93454
33aNPI1447244256assigned 09/07/2005
33bProvider typePain Medicine (Physical Medicine & Rehabilitation) Physician
28Total paid$33.42M
24GClaims984,179
24DCodes billed105
24AFirst – last monthJan 2018 – May 2021
Compared with peers
Next to other Pain Medicine (Physical Medicine & Rehabilitation) Physician providers in California
Rank by total paid#1 of 70
Median peer was paid$39K
This provider vs. median867×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 307,862 | $9.24M | |
| 2019 | 316,245 | $12.06M | |
| 2020 | 285,389 | $9.50M | |
| 2021 | 74,683 | $2.63M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 20% | 250,429 | 232,853 | $6.56M |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 17% | 46,324 | 44,877 | $5.53M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.4% | 73,518 | 66,893 | $3.14M |
| 88356 | 5.5% | 13,096 | 8,757 | $1.83M | |
| 95886 | 4.0% | 16,941 | 16,301 | $1.33M | |
| 99490 | Ccm add 20min | 3.9% | 76,554 | 76,024 | $1.30M |
| 88360 | 3.6% | 7,887 | 7,829 | $1.21M | |
| 64493 | 2.9% | 15,025 | 7,753 | $978K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.5% | 8,852 | 8,772 | $824K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2.5% | 47,854 | 46,730 | $819K |
| 95911 | 2.2% | 8,412 | 8,312 | $742K | |
| 88319 | 2.1% | 7,948 | 7,891 | $717K |
93 more codes
| 64483 | 1.8% | 8,967 | $610K | |
| 64635 | 1.6% | 4,792 | $540K | |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 1.5% | 4,698 | $511K |
| 88314 | 1.5% | 8,819 | $508K | |
| 95913 | 1.4% | 3,553 | $466K | |
| 99204 | Doctor's office visit, new patient (more involved) | 1.4% | 9,882 | $465K |
| Q3014 | Telehealth originating site facility fee | 1.1% | 19,289 | $378K |
| 96138 | <1% | 24,608 | $327K | |
| 64494 | <1% | 14,045 | $291K | |
| 64636 | <1% | 4,716 | $288K | |
| 99205 | Prolong outpt/office vis | <1% | 1,636 | $262K |
| J3490 | Unclassified drugs | <1% | 25,502 | $262K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 5,965 | $258K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 7,370 | $235K |
| 64490 | <1% | 2,898 | $230K | |
| 11104 | <1% | 4,185 | $227K | |
| 64484 | <1% | 3,532 | $187K | |
| 20611 | <1% | 8,007 | $176K | |
| 99000 | <1% | 97,068 | $156K | |
| 11105 | <1% | 4,144 | $132K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 10,835 | $125K |
| 96103 | <1% | 11,284 | $115K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,880 | $112K |
| 64495 | <1% | 5,056 | $111K | |
| 76942 | <1% | 3,952 | $107K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 952 | $105K |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 8,146 | $67K |
| 95910 | <1% | 941 | $67K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 7,287 | $67K |
| 11100 | <1% | 2,622 | $63K | |
| 64491 | <1% | 2,639 | $62K | |
| 64633 | <1% | 392 | $61K | |
| 20553 | <1% | 1,347 | $61K | |
| 95912 | <1% | 489 | $59K | |
| 64479 | <1% | 643 | $57K | |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 18,245 | $55K |
| 99152 | <1% | 10,651 | $53K | |
| 11101 | <1% | 2,572 | $52K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,312 | $51K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,174 | $38K |
| 64634 | <1% | 381 | $38K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 4,145 | $37K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,170 | $37K |
| 95924 | <1% | 529 | $37K | |
| 80306 | <1% | 1,272 | $30K | |
| 99406 | <1% | 8,848 | $29K | |
| 27096 | <1% | 119 | $27K | |
| 88341 | <1% | 575 | $26K | |
| 88342 | <1% | 575 | $23K | |
| 99442 | <1% | 1,380 | $19K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,183 | $18K |
| 20526 | <1% | 462 | $17K | |
| 64492 | <1% | 695 | $15K | |
| 99487 | Ccm add 20min | <1% | 102 | $11K |
| 99443 | <1% | 650 | $9K | |
| 80305 | <1% | 1,027 | $8K | |
| 97026 | <1% | 3,161 | $8K | |
| 64480 | <1% | 80 | $6K | |
| 99243 | <1% | 173 | $6K | |
| 97813 | <1% | 4,212 | $6K | |
| 97814 | <1% | 4,207 | $6K | |
| 20552 | <1% | 152 | $4K | |
| 96127 | <1% | 2,604 | $3K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 322 | $3K |
| 20610 | <1% | 46 | $2K | |
| 76882 | <1% | 78 | $2K | |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg | <1% | 238 | $1K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 52 | $915.96 |
| 95909 | <1% | 16 | $904.33 | |
| 90837 | Psychotherapy session, about an hour | <1% | 78 | $888.39 |
| 95923 | <1% | 298 | $800.00 | |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | <1% | 21 | $768.34 |
| 99489 | Ccm add 20min | <1% | 15 | $759.90 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 35 | $682.86 |
| 81025 | <1% | 357 | $561.88 | |
| 95908 | <1% | 52 | $528.86 | |
| 11721 | <1% | 47 | $278.32 | |
| 99407 | <1% | 14 | $263.11 | |
| 62323 | <1% | 33 | $220.03 | |
| 99441 | <1% | 66 | $193.37 | |
| 95957 | <1% | 25 | $104.71 | |
| 11720 | <1% | 14 | $54.52 | |
| 97124 | <1% | 2,631 | $43.76 | |
| 97016 | <1% | 2,169 | $8.86 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 329 | $0.00 |
| 97810 | 0% | 2,003 | $0.00 | |
| 76881 | 0% | 53 | $0.00 | |
| 63650 | 0% | 13 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 354 | $0.00 |
| 92285 | 0% | 37 | $0.00 | |
| 3079F | 0% | 54 | $0.00 | |
| 3075F | 0% | 55 | $0.00 | |
| 92250 | 0% | 37 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAGATTUTA, FRANCIS (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Lags Recovery Centers, INC. | Santa Maria, CA | $5.55M |
| Spine and Pain Treatment Medical Center of Santa Barbara INC. | Fresno, CA | $1.03M |
| Lags Spine and Sportscare Medical Centers, INC. | Reno, NV | $14K |
| Spine and Pain Treatment Medical Center of Santa Maria INC | Santa Maria, CA | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.